The John Muir Health Clinical Research Center has participated in over 500 clinical research studies. These include federally funded trials as well as pharmaceutical and biotechnological industry-sponsored studies. Our research experience includes Phase II, III, and IV drug and device clinical research studies for prevention, early detection, and treatment of various conditions.
All John Muir Health Clinical Research Center staff are certified through either the Association of Clinical Research Professionals (ACRP) or the Society of Clinical Research Associates (SoCRA).
In cancer research, we work with physicians who have extensive research experience in oncology, including blood (lymphoma, leukemia), brain, breast, colorectal, esophageal, gynecological, lung, and prostate cancers. These physicians, who function as the research investigators, include surgeons, medical oncologists, and radiation oncologists.
We have an active cardiovascular research program and provide treatment and prevention options for a variety of conditions such as hypertension, acute myocardial infarction, coronary artery disease and heart failure. These trials are primarily industry sponsored drug and device trials.
Other areas of research include neurology, orthopaedic, pulmonology, radiology, and nursing research studies.
John Muir Physician Network Clinical Research Center has completed over 450 clinical trials for the pharmaceutical and biotechnological industries, with focus on Phase II, III, and IV clinical trials. We provide rapid enrollment, high data integrity, and compassionate care to our research subjects. Our research medical directors have over 18 years of clinical research experience. Our research coordinators are RNs and CDEs, with significant experience in diabetes mellitus and its complications, as well as other endocrine metabolic disorders such as obesity.
Our research focus has expanded into other therapeutic areas. We have contracted with principal investigators in cardiovascular care, dermatology, gastroenterology, neurology, and urology. Additionally, we have participated in more than 75 device studies for both invasive and noninvasive glucose monitors, glucose sensors, HbA1c testing, and lipid measuring devices.